Loading…
Revvity, Inc. is projected to rise to $148.88 by 2027, a +31% move from its current price of $113.54. RVTY is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $111.47 | $113.61 | $115.79 | +0.06% |
| Aug 2 | $110.67 | $113.68 | $116.78 | +0.13% |
| Aug 3 | $110.07 | $113.76 | $117.57 | +0.19% |
| Aug 4 | $109.58 | $113.83 | $118.24 | +0.25% |
| Aug 5 | $109.16 | $113.90 | $118.85 | +0.32% |
| Aug 6 | $108.79 | $113.97 | $119.41 | +0.38% |
| Aug 7 | $108.45 | $114.05 | $119.93 | +0.45% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $108.45 | $114.05 | $119.93 | +0.45% |
| Week 2 | $106.69 | $114.56 | $123.00 | +0.89% |
| Week 3 | $105.46 | $115.07 | $125.54 | +1.34% |
| Week 4 | $104.52 | $115.58 | $127.82 | +1.80% |
| Week 5 | $103.74 | $116.10 | $129.92 | +2.25% |
| Week 6 | $103.09 | $116.61 | $131.91 | +2.71% |
| Week 7 | $102.54 | $117.13 | $133.81 | +3.17% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Revvity, Inc. operates in the healthcare sector as a provider of health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services, and a range of instruments, reagents, assay platforms and software products for early detection of common and rare conditions, including pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.
It also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. The company serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. Revvity, Inc.
was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity was founded in 1937 and is headquartered in Waltham, Massachusetts.
RVTY trades in the healthcare space with a current price of $110.47 and a market capitalization of $12.32B. It ranks 778 by market cap.
The near-term price outlook is indicated by the 2026 forecast, which shows an average price of $110.47, with a potential range from $82.26 to $153.09 and a neutral sentiment.
Looking further out, the forecast envisions a bullish path with the average price rising to $245.58 by 2030, $632.18 by 2040, and $1,570.49 by 2050, delivering substantial upside across the horizon. The corresponding ROIs are 122.3% by 2030, 472.3% by 2040, and 1321.6% by 2050, underscoring a strong longer-term upside despite near-term variability.
A major floor 27.5% below — a decisive break under it would weaken the trend.
The nearest floor, 13.8% below — buyers have tended to step in here.
Price is pressing into resistance (0.2% away) — a breakout level to watch.
A major ceiling 9.5% above — clearing it would confirm fresh momentum.
Key RVTY support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of RVTY market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $111.39 | Buy | $112.14 | Buy |
| MA 10 | $110.78 | Buy | $111.47 | Buy |
| MA 20 | $111.33 | Buy | $110.44 | Buy |
| MA 50 | $105.69 | Buy | $106.31 | Buy |
| MA 100 | $97.89 | Buy | $102.36 | Buy |
| MA 200 | $98.81 | Buy | $100.02 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 58.32 | Neutral |
| Stoch RSI (14) | 88.32 | Sell |
| CCI (20) | 104.99 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | -0.20 | Sell |
| ROC (12) | 2.10 | Buy |
| Bollinger %B (20,2) | 0.80 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.26 | Buy |
| Awesome (5,34) | 2.75 | Buy |
| Ultimate (7,14,28) | 59.07 | Neutral |
| Momentum (10) | 1.84 | Buy |
| Aroon Osc (25) | 24.00 | Buy |
| Hull MA (9) | 112.47 | Buy |
| ADX (14) | 15.95 | Neutral |
| ATR (14) | 1.88 | Info |
The 30-day technical picture is bullish, with RSI(14) at 60 and the 50-day simple moving average at $104.15, above the 200-day moving average at $98.31.
Support is seen at $97.82 and resistance at $113.76, with the 30-day range spanning from $97.15 to $125.62.
The current sentiment for the short-term picture aligns with the bullish setup suggested by the 30-day range and moving averages.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $82.26 | $113.54 | $156.02 | 0% | Neutral | |
| $122.01 | $148.88 | $189.90 | +31% | Bullish | |
| $146.18 | $181.82 | $238.34 | +60% | Bullish | |
| $178.89 | $226.00 | $302.67 | +99% | Bullish | |
| $194.64 | $249.27 | $339.95 | +120% | Bullish | |
| $213.64 | $276.99 | $383.80 | +144% | Bullish | |
| $229.92 | $301.51 | $423.81 | +166% | Bullish | |
| $240.92 | $319.32 | $454.72 | +181% | Bullish | |
| $281.49 | $376.85 | $543.13 | +232% | Bullish | |
| $331.98 | $448.71 | $653.98 | +295% | Bullish | |
| $446.67 | $630.02 | $962.71 | +455% | Bullish | |
| $1,028.20 | $1,556.80 | $2,551.50 | +12.7x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $82.26 | $113.54 | $132.21 | +0.00% |
| August 2026 | $99.96 | $116.57 | $138.55 | +2.67% |
| September 2026 | $102.58 | $120.32 | $144.37 | +3.22% |
| October 2026 | $102.38 | $120.64 | $145.84 | +0.27% |
| November 2026 | $103.38 | $122.28 | $148.71 | +1.36% |
| December 2026 | $107.49 | $127.58 | $156.02 | +4.34% |
Click any year to see its month-by-month RVTY forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect RVTY to range from $82.26 to $156.02 through 2026. The $113.54 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The RVTY price prediction for 2027 points to an average of $148.88 (low $122.01, high $189.90) — a potential gain of +31% on today's $113.54. Buyers look set to stay in control over this stretch.
In 2028, RVTY is projected to trade between $146.18 and $238.34, averaging $181.82 — a potential gain of +60% from today's $113.54. That is up +22% on the projected 2027 average. Momentum favours further upside here.
Revvity, Inc.'s 2029 outlook centres on $226.00, within a $178.89 to $302.67 range. That is up +24% on the projected 2028 average. That marks a +99% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, RVTY could reach as high as $339.95, with a base case around $249.27 and support toward $194.64 — roughly +120% from $113.54. Momentum favours further upside here.
Expect RVTY to range from $213.64 to $383.80 through 2031. The $276.99 average target implies a +144% move from current prices. That is up +11% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The RVTY price prediction for 2032 points to an average of $301.51 (low $229.92, high $423.81) — a potential gain of +166% on today's $113.54. Momentum favours further upside here.
In 2033, RVTY is projected to trade between $240.92 and $454.72, averaging $319.32 — a potential gain of +181% from today's $113.54. That is up +6% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Revvity, Inc.'s 2034 outlook centres on $376.85, within a $281.49 to $543.13 range. That is up +18% on the projected 2033 average. That marks a +232% change versus current levels. Momentum favours further upside here.
By 2035, RVTY could reach as high as $653.98, with a base case around $448.71 and support toward $331.98 — roughly +295% from $113.54. Buyers look set to stay in control over this stretch.
Expect RVTY to range from $446.67 to $962.71 through 2040. The $630.02 average target implies a +455% move from current prices. That is up +40% on the projected 2035 average. Momentum favours further upside here.
The RVTY price prediction for 2050 points to an average of $1,556.80 (low $1,028.20, high $2,551.50) — a potential gain of +12.7x on today's $113.54. Buyers look set to stay in control over this stretch.
Investing $1,000 in RVTY today (≈ 8.807469 RVTY) could be worth
$13,711.44
+$12,711.44 (+1271%) by 2050 · US Dollar
Based on the average projected RVTY price of $1,556.8 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in RVTYwould be worth at today's price.
$1,000 invested in RVTY on Jul 30, 2025 (≈ 11.007155 RVTY) would be worth
$1,249.75
+$249.75 (+25.0%) today · 1.25× · US Dollar
Based on a RVTY entry price of $90.85 vs. today's $113.54.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $113.17 | $1,003.27 | +0.3% |
| 1 month ago | $111.26 | $1,020.49 | +2.0% |
| 3 months ago | $86.68 | $1,309.88 | +31.0% |
| 6 months ago | $108.8 | $1,043.57 | +4.4% |
| 1 year ago | $90.85 | $1,249.75 | +25.0% |
| All time (5.0y) ago | $183.84 | $617.6 | -38.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our RVTY forecast.
Our base-case forecast reaches $230.00 around 2030.
Implied market cap at $230.00: $25.66B
Over the multi-year horizon, the forecast shows a bullish trajectory with annual average prices rising from $110.47 in 2026 to $245.58 in 2030 and to $1,570.49 by 2050.
By 2030, the average is $245.58 with an ROI of 122.3% and bullish sentiment. By 2040, the average is $632.18 with an ROI of 472.3% and bullish sentiment, and by 2050 the average is $1,570.49 with an ROI of 1321.6% and bullish sentiment.
The forecast also shows substantial year-by-year upside across the period (e.g., 2027 avg $145.63, 2028 avg $178.88, 2029 avg $223.37), but these are estimates and not guarantees. Risks include variability indicated by the 2026 min $82.26 and max $153.09 despite longer-term upside.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $245.58, with a min of $191.18 and a max of $336.25; ROI is 122.3% and sentiment is BULLISH.
The forecast projects a bullish trajectory beyond 2026, with the 2030 average at $245.58 and the 2050 average at $1,570.49 (ROI 1321.6%), indicating meaningful upside in the longer term, but these are estimates and not guaranteed.
According to the forecast, the 2040 maximum is $971.99, and the 2050 maximum is $2,593.16. A $1,000 level would not be reached by 2040 based on the provided figures.
RSI(14) is 60. The 50-day SMA is $104.15 and the 200-day SMA is $98.31. Support is $97.82 and resistance is $113.76, with a 30-day range of $97.15 to $125.62.
Current price is $110.47 and market cap is $12.32B. The asset is ranked 778 by market cap.
Revvity, Inc. Community Discussion
0Share your Revvity, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.